Development asset linked to Xenon Pharmaceuticals in public FDA and regional records.
pharma · Major Depressive Disorder · Primary Erythromelalgia · XENE
Xenon Pharmaceuticals
Xenon Pharmaceuticals drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
3650 Gilmore Way, Burnaby, BC V5G 4W8, CA HQ
397 Employees
Public company Type
XENE · NYSE Ticker
Company details
- Status
- Public
- HQ
- 3650 Gilmore Way, Burnaby, BC V5G 4W8, CA
- Employees
- 397
- Programs
- 22
- Drugs
- 2
- Patents
- 106
Xenon Pharmaceuticals pipeline
Portfolio lens on 2 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Xenon Pharmaceuticals drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Xenon Pharmaceuticals in public FDA and regional records.